TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Condition:   Ulcerative Colitis (UC) Interventions:   Drug: TD-1473 Dose A;   Drug: TD-1473 Dose B;   Drug: TD-1473 Dose C Sponsor:   Theravance Biopharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials